Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5615387 | Journal of Clinical Lipidology | 2017 | 5 Pages |
Abstract
We present the case history of 2 patients with low-density lipoprotein receptor-negative compound heterozygous familial hypercholesterolemia who did not receive lipoprotein apheresis. We describe the subsequent effect of all lipid-lowering medications during their life course including resins, statins, ezetimibe, nicotinic acid/laropiprant, mipomersen, and lomitapide. These cases tell the story of siblings affected with this rare disease, who are free of symptoms but still are at a very high cardiovascular disease risk, and their treatment from childhood.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Reyhana MD, Monique T. PhD, Eric J.G. Prof, MD, PhD, Monique MD, PhD, Jeanine E. MD, PhD,